| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $811.7M | -1.3% | +11.0% |
| Cost of Revenue | $150.9M | -0.6% | +7.1% |
| Gross Profit | $660.8M | -1.5% | +12.0% |
| R&D Expense | $151.0M | +7.0% | +10.6% |
| SG&A Expense | $91.6M | +1.2% | +19.6% |
| Operating Income | $179.0M | -16.4% | +12.7% |
| Pre-tax Income | $189.2M | -15.1% | +10.5% |
| Income Tax | $41.5M | -3.3% | +61.5% |
| Net Income | $147.8M | -17.9% | +1.5% |
| EPS (Basic) | $2.61 | -16.3% | +4.0% |
| EPS (Diluted) | $2.58 | -16.8% | +4.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.44B | +20.3% | +14.6% |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $425.6M | -13.8% | +12.1% |
| Inventory | $90.3M | +13.0% | +33.0% |
| Current Assets | $2.70B | +7.4% | +15.7% |
| Total Assets | $6.50B | +3.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $525.1M | +229.8% | — |
| Capital Expenditures | $28.1M | +188.7% | — |
| Investing Cash Flow | -$29.2M | -176.9% | — |
| Financing Cash Flow | -$396.3M | -35.2% | — |
| Free Cash Flow | $497.1M | +232.5% | — |
| +10.0% |
| Current Liabilities | $1.68B | +3.6% | +10.0% |
| Stockholders' Equity | $3.65B | +3.1% | +10.1% |